Editorial
doi: 10.1056/NEJM199809103391109.
Appetite suppressants and valvular heart disease
- PMID: 9731094
- DOI: 10.1056/NEJM199809103391109
Item in Clipboard
Editorial
Appetite suppressants and valvular heart disease
N Engl J Med.
.
No abstract available
Comment on
-
The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs.N Engl J Med. 1998 Sep 10;339(11):713-8. doi: 10.1056/NEJM199809103391101. N Engl J Med. 1998. PMID: 9731086
-
A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation.N Engl J Med. 1998 Sep 10;339(11):719-24. doi: 10.1056/NEJM199809103391102. N Engl J Med. 1998. PMID: 9731087
-
An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group.N Engl J Med. 1998 Sep 10;339(11):725-32. doi: 10.1056/NEJM199809103391103. N Engl J Med. 1998. PMID: 9731088 Clinical Trial.
Similar articles
-
Studies confirm link between fen-phen and heart-valve disease.Harv Heart Lett. 1998 Dec;9(4):4-6. Harv Heart Lett. 1998. PMID: 9925979 No abstract available.
-
Valvular heart disease associated with fenfluramine-phentermine.N Engl J Med. 1997 Dec 11;337(24):1773-4; author reply 1775. N Engl J Med. 1997. PMID: 9411249 No abstract available.
-
Further cases of valvular heart disease associated with fenfluramine-phentermine.N Engl J Med. 1997 Aug 28;337(9):635. doi: 10.1056/NEJM199708283370911. N Engl J Med. 1997. PMID: 9280830 No abstract available.
-
[Valvular heart disease and primary pulmonary hypertension associated with fenfluramine-phentermine].Harefuah. 1998 Dec 1;135(11):515-7. Harefuah. 1998. PMID: 10911468 Review. Hebrew. No abstract available.
-
Current status of fenfluramine/dexfenfluramine-induced cardiac valvulopathy.J Calif Dent Assoc. 1999 May;27(5):400-4. J Calif Dent Assoc. 1999. PMID: 10528558 Review.
Cited by
-
Serotonergic drugs and valvular heart disease.Expert Opin Drug Saf. 2009 May;8(3):317-29. doi: 10.1517/14740330902931524. Expert Opin Drug Saf. 2009. PMID: 19505264 Free PMC article. Review.
-
Recent advances in clinical practice challenges and opportunities in the management of obesity.Gut. 2014 Apr;63(4):687-95. doi: 10.1136/gutjnl-2013-306235. Epub 2014 Jan 8. Gut. 2014. PMID: 24402654 Free PMC article. Review.
-
Appetite suppressants, cardiac valve disease and combination pharmacotherapy.Am J Ther. 2009 Jul-Aug;16(4):354-64. doi: 10.1097/MJT.0b013e31817fde95. Am J Ther. 2009. PMID: 19092640 Free PMC article. Review.
-
Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons.Nat Rev Drug Discov. 2012 Sep;11(9):675-91. doi: 10.1038/nrd3739. Epub 2012 Aug 3. Nat Rev Drug Discov. 2012. PMID: 22858652 Review.
-
Effects of caffeoylquinic acid analogs derived from aerial parts of Artemisia iwayomogi on adipogenesis.Food Sci Biotechnol. 2023 Feb 6;32(9):1215-1223. doi: 10.1007/s10068-023-01262-9. eCollection 2023 Aug. Food Sci Biotechnol. 2023. PMID: 37362808 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
